73 related articles for article (PubMed ID: 7504209)
1. CD44--a new prognostic marker for neuroblastoma.
Favrot MC; Combaret V; Lasset C
N Engl J Med; 1993 Dec; 329(26):1965. PubMed ID: 7504209
[No Abstract] [Full Text] [Related]
2. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
Gross N; Beretta C; Peruisseau G; Jackson D; Simmons D; Beck D
Cancer Res; 1994 Aug; 54(15):4238-42. PubMed ID: 7518353
[TBL] [Abstract][Full Text] [Related]
3. CD44v6 expression in non-Hodgkin's lymphoma: an association with low histological grade and poor prognosis.
Ristamäki R; Joensuu H; Söderström KO; Jalkanen S
J Pathol; 1995 Jul; 176(3):259-67. PubMed ID: 7545748
[TBL] [Abstract][Full Text] [Related]
4. Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer.
Guo YJ; Liu G; Wang X; Jin D; Wu M; Ma J; Sy MS
Cancer Res; 1994 Jan; 54(2):422-6. PubMed ID: 7506122
[TBL] [Abstract][Full Text] [Related]
5. CD44 expression in colorectal adenomas is an early event occurring prior to K-ras and p53 gene mutation.
Kim H; Yang XL; Rosada C; Hamilton SR; August JT
Arch Biochem Biophys; 1994 May; 310(2):504-7. PubMed ID: 7513984
[TBL] [Abstract][Full Text] [Related]
6. Ha-ras p21 in neuroblastoma: a new marker in prediction of patient outcome.
Tanaka T
Prog Clin Biol Res; 1994; 385():275-80. PubMed ID: 7972221
[No Abstract] [Full Text] [Related]
7. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
Wielenga VJ; Heider KH; Offerhaus GJ; Adolf GR; van den Berg FM; Ponta H; Herrlich P; Pals ST
Cancer Res; 1993 Oct; 53(20):4754-6. PubMed ID: 7691404
[TBL] [Abstract][Full Text] [Related]
8. Expression of integrin and CD44 adhesion molecules on neuroblastoma: the relation to tumor aggressiveness and embryonic neural-crest differentiation.
Combaret V; Coll JL; Favrot MC
Invasion Metastasis; 1994-1995; 14(1-6):156-63. PubMed ID: 7544774
[TBL] [Abstract][Full Text] [Related]
9. [Tumor markers--personal experience. Ha-ras P21 in neuroblastoma: a new marker associating to patient's prognosis].
Tanaka T
Gan To Kagaku Ryoho; 1991 Jan; 18(1):143-50. PubMed ID: 1987897
[TBL] [Abstract][Full Text] [Related]
10. Splice variants of CD44 in human cervical cancer stage IB to IIB.
Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
[TBL] [Abstract][Full Text] [Related]
11. [The immunological cellular phenotype and the prognosis in neuroblastoma in children].
Novikov AM; Blinov VM; Bukhny AF; Bassalyk LS
Vopr Onkol; 1990; 36(6):693-7. PubMed ID: 2378089
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors in neuroblastoma in children].
Izbicki T; Laskowska-Klita T; Liebhart M; Lipińska L
Pediatr Pol; 1995 Nov; 70(11):949-53. PubMed ID: 8677161
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?
Humphrey G; Hazel DL; MacLennan K; Lewis I
Br J Cancer; 1999 May; 80(5-6):918-21. PubMed ID: 10360676
[TBL] [Abstract][Full Text] [Related]
14. Neuroblastoma in the very young child: biological considerations.
Kemshead JT; Patel K; Phimister B
Br J Cancer Suppl; 1992 Aug; 18():S102-5. PubMed ID: 1503919
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma: biology, prognosis, and treatment.
Park JR; Eggert A; Caron H
Pediatr Clin North Am; 2008 Feb; 55(1):97-120, x. PubMed ID: 18242317
[TBL] [Abstract][Full Text] [Related]
16. A developmental model of neuroblastoma: differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage.
Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Påhlman S
Lab Invest; 1996 Nov; 75(5):659-75. PubMed ID: 8941212
[TBL] [Abstract][Full Text] [Related]
17. CD44 expression in human bone: a novel marker of osteocytic differentiation.
Hughes DE; Salter DM; Simpson R
J Bone Miner Res; 1994 Jan; 9(1):39-44. PubMed ID: 7512306
[TBL] [Abstract][Full Text] [Related]
18. Changes in CD44 expression during B cell differentiation in the human tonsil.
Kremmidiotis G; Zola H
Cell Immunol; 1995 Apr; 161(2):147-57. PubMed ID: 7535194
[TBL] [Abstract][Full Text] [Related]
19. CD44 family and gynaecological cancer.
Makrydimas G; Zagorianakou N; Zagorianakou P; Agnantis NJ
In Vivo; 2003; 17(6):633-40. PubMed ID: 14758731
[TBL] [Abstract][Full Text] [Related]
20. Histopathological features of pretreatment neuroblastoma are of limited clinical significance following adjustment for clinical and biological marker status.
Sebire NJ
Med Hypotheses; 2006; 66(6):1078-81. PubMed ID: 16413685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
